Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation.

Clinical genetics - 1 Jan 2014

Metcalfe K A, Kim-Sing C, Ghadirian P, Sun P, Narod S A

Abstract excerpt

There is a significant variation in the uptake of cancer risk reducing options by women with a BRCA1 or BRCA2 mutation. It is currently unclear why these differences exist and it is possible that recommendations vary between providers and these influence patient decisions. Eligible health care providers who provide genetic counseling for hereditary breast and ovarian cancer families in Canada were identified....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Canada
Share to Genes, BRCA2
Share to Health Personnel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Mastectomy

Share to Ovariectomy

Share to Practice Guidelines as Topic

Share to Tamoxifen

Source

Identifiers

PMID: 23859469
DOI: 10.1111/cge.12233

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation.PMID 23859469Read ↗

Risk-reduction surgery decisions in high-risk women seen for genetic counseling.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Selected Medical Interventions in Women With a Deleterious Brca Mutation: A Population-Based Study in British ColumbiaSemantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic.Semantic proximity Read ↗

Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with BRCA1/2 Pathogenic Variants: A Population-Based Retrospective Cohort Study.Semantic proximity Read ↗

Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.Semantic proximity Read ↗

Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done.Semantic proximity Read ↗

Uptake of Screening and Risk Reducing Recommendations Among Women with Hereditary Breast and Ovarian Cancer Syndrome Evaluated at a Large Urban Comprehensive Cancer CenterSemantic proximity Read ↗

Risk management options elected by women after testing positive for a BRCA mutation.Semantic proximity Read ↗

Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with <em>BRCA1/2</em> Pathogenic Variants: A Population-Based Retrospective Cohort StudySemantic proximity Read ↗

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.